| HOME >> BIOLOGY >> TECHNOLOGY |
ANN ARBOR, Mich., April 16 /PRNewswire/ --
When: Tuesday, April 22
Workshop 2 - 5:30 p.m.
Networking Reception 5:30 p.m.
Dinner Program 6:30 p.m.
Where: 610 Hilton Blvd., Ann Arbor 48108 (map:
http://www.kcourtaa.com/ann_arbor_city_map_directions.html)
Workshop: Capital Formation: Lost in Translation
Industry experts will demystify the benefits,
processes and lingo involved in raising money from
non-dilutive funding like SBIR and STTR programs,
debt sources such as the Michigan Economic
Development Corp., and equity sources such as venture
capital and corporate investment. How to select the
best funding source and create a compelling message
will also be discussed. Break-out sessions will
evaluate a case study in each area. This will be a
valuable gathering for those involved or interested
in starting or growing life sciences businesses.
Speakers: Roger Newton, former president, Esperion
Therapeutics, senior VP, Pfizer; Jeff LaBine,
principal, Miller Canfield; Ian Bund, chairman,
Plymouth Venture Partners; Timothy Mayleben,
president, and COO, Nighthawk Radiology Holdings;
Andy Jakimcius, Principal Consultant, Biotechnology
Business Consultants; Wayne Harvey, Senior Business
Development Speci
'/>"/>
| SOURCE MichBio Copyright©2008 PR Newswire. All rights reserved |